| 41 |
|
A kinder and gentler CHOP?/
|
Hochster, H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 42 |
|
Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells/
|
Wang, X
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 43 |
|
ALG/ATG: illuminating the occult/
|
Steensma, D. P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 44 |
|
ALK in NHL: To B (cell) or not to B (cell)? Characterization of the entity "ALK^+ DLBCL"/
|
Morris, S. W
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 45 |
|
ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases/
|
Gascoyne, R. D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 46 |
|
Allogeneic hematopoietic stem cell transplantation for myelofibrosis/
|
Deeg, H. J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 47 |
|
Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever/
|
Touitou, I
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 48 |
|
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma/
|
Maloney, D. G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 49 |
|
alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry/
|
Weigel-Kelley, K. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 50 |
|
Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val/
|
Doggett, T. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 51 |
|
Alternative 5' exons and differential splicing regulate expression of protein 4.1R isoforms with distinct N-termini/
|
Parra, M. K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 52 |
|
A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy/
|
Stoll, B. R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 53 |
|
AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma/
|
Choi, S. J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 54 |
|
AML: clustering genes to predict outcome/
|
Ness, S. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 55 |
|
AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases/
|
Schoch, C
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 56 |
|
Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases/
|
Wolf, K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 57 |
|
A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3^+ LGL-leukemia/
|
Valmori, D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 58 |
|
Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor/
|
Michaux, G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 59 |
|
A naturally occurring Tyr143Hisalpha~I~I~b mutation abolishes alpha~I~I~bbeta~3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects/
|
Kiyoi, T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 60 |
|
...And so on to viscosity/
|
Embury, S. H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|